Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-06-27 @ 11:50 AM
Study NCT ID:
NCT07011550
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2025-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization: